Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Apr 2, 2020. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-0001-25
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)
- Initial Posting
- Apr 2, 2020
Reason
Demand increase for the drug